Mirae Asset Global ETFs Holdings’s Immunovant IMVT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.78M	Buy	72,169 +368	+0.5%	+$11.2K	﹤0.01%	1094
2026 Q1	$1.77M	Buy	71,801 +31,496	+78%	+$815K	﹤0.01%	1231
2025 Q4	$1.02M	Buy	40,305 +3,354	+9%	+$74.8K	﹤0.01%	1505
2025 Q3	$595K	Sell	36,951 -5,690	-13%	-$92.1K	﹤0.01%	1782
2025 Q2	$683K	Buy	42,641 +1,670	+4%	+$25.3K	﹤0.01%	1644
2025 Q1	$708K	Buy	40,971 +3,348	+9%	+$70K	﹤0.01%	1669
2024 Q4	$928K	Sell	37,623 -143	-0.4%	-$4.06K	﹤0.01%	1585
2024 Q3	$1.07M	Buy	37,766 +4,810	+15%	+$142K	﹤0.01%	1505
2024 Q2	$868K	Buy	+32,956	New	+$937K	﹤0.01%	1532

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's IMVT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Immunovant (IMVT) stake by 0.51% in Q2 2026, buying an estimated $11.2K and bringing the position to 72,169 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Mirae Asset Global ETFs Holdings first reported a position in IMVT in Q2 2024 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 72,169 shares of Immunovant worth $2.78M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 368 Immunovant shares in Q2 2026, an estimated $11.2K.
Immunovant made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1094 holding.
Mirae Asset Global ETFs Holdings first reported a position in Immunovant in Q2 2024 and has held it in 9 quarters since.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.